By Professor Bruce James Brew

Journal articles

Cysique LA; Maruff P; Brew BJ, 2006, 'Variable benefit in neuropsychological function in HIV-infected HAART-treated patients', Neurology, 66, pp. 1447 - 1450

Brew B, 2005, 'Relativity and relativism [9]', New Scientist, 188, pp. 27

Guillemin GJ; Cullen KM; Smythe GA; Brew BJ, 2005, 'Involvement of the kynurenine pathway in neuroinflammation', INFLAMMATION RESEARCH, 54, pp. S199 - S199, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600371&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guillemin GJ; Brew BJ; Noonan CE; Knight TG; Smythe G; Callen KM, 2005, 'Mass spectroscopic detection of quinolinic acid in microdissected Alzheimer's disease plaques', INFLAMMATION RESEARCH, 54, pp. S200 - S200, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000205501600374&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid selectively induces apoptosis of human astocytes: Potential role in AIDS dementia complex', Journal of Neuroinflammation, 2, http://dx.doi.org/10.1186/1742-2094-2-16

Batmanian J; Brew BJ, 2005, 'Clinical significance of central nervous system as sanctuary site for HIV', Journal of HIV therapy, 10, pp. 16 - 21

Berger J; Brew BJ, 2005, 'An international screening tool for HIV dementia', AIDS, 19, pp. 2165 - 2166

Brew BJ; Pemberton LA; Blennow K; Wallin A; Hagberg L, 2005, 'CSF amyloid beta 42 and tau levels correlate with AIDS dementia complex', Neurology, 65, pp. 1490 - 1492

Winston A; Marriott D; Brew BJ, 2005, 'Early syphilis presenting as a painful polyradiculopathy in an HIV positive individual', Sexually Transmitted Infections, 81, pp. 133 - 134

Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3 dioxygenase and production of quinolinic acid by human microglia, astrocytes and neurons', Glia, 49, pp. 15 - 23

Guillemin GJ; Smythe GA; Takikawa O; Brew BJ, 2005, 'Expression of indoleamine 2,3-dioxygenase and production of quinolinicacid by human microglia, astrocytes, and neurons', Glia, 49, pp. 15 - 23

Brew BJ, 2005, 'HIV and the nervous system - palliative carte aspects', Journal of the Neurological Sciences, 238, pp. S38 - S38

Brew BJ, 2005, 'HIV associated neurology in the developing world', Journal of the Neurological Sciences, 238, pp. S22 - S22

Brew BJ, 2005, 'HIV related neuromuscular disease', Journal of the Neurological Sciences, 238, pp. S3 - S3

Lamour Y; Veas LA; Lamoury F; Brew BJ, 2005, 'Human mesenchymal stem cells constitutively express chemokines and chemokine receptors which can be upregulated by cytokines, ifn-beta and copaxone', Journal of the Neurological Sciences, 238, pp. S233 - S233

Crowe S; Ho D; Marriott D; Brew BJ; Gorry P; Sullivan JS; Learmont JC; Mills J, 2005, 'In vivo replication kinetics of a nef-deleted strain of HIV-1', AIDS, 19, pp. 842 - 843, http://journals.lww.com/aidsonline/Fulltext/2005/05200/In_vivo_replication_kinetics_of_a_nef_deleted.17.aspx

Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer`s disease hippocampus', Neuropathology and Applied Neurobiology, 31, pp. 395 - 404

Guillemin GJ; Brew BJ; Noonan C; Takikawa O; Cullen K, 2005, 'Indoleamine 2,3 dioxygenase and quinolinic acid in plaque and neurons in post-mortem brain tissue from Alzheimer`s disease and control cases', Neuropathology and Applied Neurobiology, 31, pp. 395 - 404

Guillemin GJ; Kerr SJ; Brew BJ, 2005, 'Involvement of quinolinic acid in AIDS dementia complex', Neurotoxicity Research, 7, pp. 103 - 123

McArthur J; Brew BJ; Nath A, 2005, 'Neurological complications of HIV infection', Lancet Neurology, 4, pp. 543 - 555, http://www.sciencedirect.com/science/article/B6X3F-4GWTGXT-N/2/31ef81879a7f7d44e856e780c21aaf2d

Guillemin GJ; Wang L; Brew BJ, 2005, 'Quinolinic acid induces apoptosis of human astrocyte', Journal of Neuroinflammation

Cysique LA; Brew BJ; Halman M; Catalan J; Sacktor N; Price R; Brown S; Atkinson JH; Clifford D; Simpson D; Torres G; Hall C; Power C; Marder K; McArthur J; Symonds W; Romero C, 2005, 'Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 39, pp. 426 - 429

Churchill M; Sterjovski J; Gray L; Cowley D; Chatfield C; Learmont J; Sullivan JS; Crowe SM; Mills J; Brew BJ; Wesselingh SL; McPhee DA; Gorry PR, 2004, 'Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia', Journal of Infectious Diseases, 190, pp. 2181 - 2186, http://dx.doi.org/10.1086/425585

Brew BJ, 2004, 'HAART in AIDS dementia complex and palliative care', Progress in Palliative Care, 12, pp. 171 - 177, http://dx.doi.org/10.1179/096992604225006370

Brew BJ, 2004, 'Clinical aspects of AIDS dementia complex in the HAART era', JOURNAL OF NEUROVIROLOGY, 10, pp. 3 - 3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000202992000003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cysique LA; Maruff P; Brew BJ, 2004, 'Antiretroviral therapy in HIV infection: are neurologically active drugs important?', Archives of Neurology, 61, pp. 1699 - 1704, http://www.sciencedirect.com/science/article/B6WVB-4DSGX8W-DY/2/7ff0db503b2a662c0b31ccb94702dd10

Brew BJ; Pemberton LA; Ray J, 2004, 'Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?', Journal of Neurovirology, 10 Suppl 1, pp. 38 - 43

Brew BJ, 2004, 'Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex', AIDS, 18 Suppl 1, pp. S75 - S78

Brew BJ, 2004, 'Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex', AIDS, pp. 75 - 78, http://dx.doi.org/10.1097/00002030-200418001-00011

Brew BJ; Tomlinson SE, 2004, 'HIV neuropathy: time for new therapies', Drug Discovery Today-Disease Models, 1, pp. 171 - 176, http://www.sciencedirect.com/science/article/B75D8-4DJBRDY-1/2/294282aff7da50aa0413b19683a7b96f

Newell ME; Hoy JF; Cooper S; De Graaff B; Grulich AE; Bryant M; Millar JL; Brew BJ; Quinn DI, 2004, 'Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients', Cancer, 100, pp. 2627 - 2636

Smit T; Brew BJ; Tourtellotte W; Morgello S; Gelman B; Saksena NK, 2004, 'Independent evolution of human immunodeficiency virus (HIV) drugresistance mutations in diverse areas of the brain in HIV-infectedpatients, with and without dementia, on antiretroviral treatment', Journal of Virology, 78, pp. 10133 - 10148

Guillemin GJ; Brew BJ, 2004, 'Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification', Journal of Leukocyte Biology, 75, pp. 388 - 397

Guillemin GJ; Brew BJ, 2004, 'Phenotypic differences and similarities between microglia, macrophage and pericyte (review)', Journal of Leukocyte Biology, 75, pp. 388 - 397

Cysique LA; Maruff P; Brew BJ, 2004, 'Prevalence and pattern of neuropsychological impairment in humanimmunodeficiency virus-infected/acquired immunodeficiency syndrome(HIV/AIDS) patients across pre- and post-highly active antiretroviraltherapy eras: A combined study of two cohorts', Journal of Neurovirology, 10, pp. 350 - 357

Guillemin GJ; Croitoru-Lamoury J; Dormont D; Armati PJ; Brew BJ, 2003, 'Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes', GLIA, 41, pp. 371 - 381, http://dx.doi.org/10.1002/glia.10175

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A1-42 induces production of quinolinic acid by human macrophages and microglia', NeuroReport, 14, pp. 165 - 181

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'A beta I-42 induces production of quinolinic acid by human macrophagesand microglia', Neuroreport, 14, pp. 2311 - 2315

Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ, 2003, 'ABeta 1-42 Induces Production of Quinolinic Acid by Human Macrophases and Microglia.', Neuroreport, 14, pp. 2311 - 2315

Guillemin GJ; Smith DG; Armati PJ; Brew BJ, 2003, 'Expression kynurenine pathway enzymes in human macrophages and microglia', Advances in Experimental Medicine and Biology, 527, pp. 105 - 112

Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ, 2003, 'Expression of the kynurenine pathway enzymes in human microglia and macrophages', Advances in Experimental Medicine and Biology, 527, pp. 105 - 112

Croitoru J; Guillemin GJ; Boussin F; Mognetti B; Gigout LI; Cheret A; Vaslin A; Le Grand AR; Brew BJ; Dormont J, 2003, 'Expressions of chemokines and their receptors in human and simian astrocytes: evidence for a central effect of TNF and IFN in CXCR4 and CCR5 modulation.', Glia, 41, pp. 354 - 370

Brew BJ; Tisch S; Law MG, 2003, 'HIV nucleoside neuropathy and HIV distal symmetrical neuropathy: relationships to serum lactate and plasma HIV viral load', AIDS, 17, pp. 1094 - 1096

Guillemin GJ; Croitoru-Lamoury J; Dormont D; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human foetal astrocytes', Advances in Experimental Medicine and Biology, 527, pp. 37 - 45

Guillemin GJ; Croitoru J; Dormont D; Armati PJ; Brew BJ, 2003, 'Involvement of quinolinic acid in chemokine production and chemokine receptor expression in human fœtal astrocytes', Glia, 41, pp. 371 - 381

Brew BJ; Tisch S; Law MG, 2003, 'Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy', AIDS, 17, pp. 1094 - 1096

Dore GJ; McDonald AM; Li Y; Kaldor JM; Brew BJ, 2003, 'Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 17, pp. 1539 - 1545

Guillemin GJ; Williams K; Smith DG; Smythe GA; Croitoru-Lamoury J; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer`s disease', Advances in Experimental Medicine and Biology, 527, pp. 167 - 176, http://www.springer.com/series/5584

Guillemin GJ; Smith DG; Williams KR; Smythe GA; Dormont D; Brew BJ, 2003, 'Quinolinic acid in the pathogenesis of Alzheimer’s disease', Advances in Experimental Medicine and Biology, 527, pp. 167 - 176

Croitoru-Lamoury J; Guillemin GJ; Dormont D; Brew BJ, 2003, 'Quinolinic acid up-regulates chemokine production and chemokinereceptor expression in astrocytes', Advances in Experimental Medicine and Biology, 527, pp. 37 - 45

Back to profile page